← Eichor
Study identifier: NCT03211793 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis

Condition: Systemic Sclerosis · Digital Ulcer  ·  Sponsor: UMC Utrecht

PhasePhase 1/Phase 2
Planned participants20
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The MANUS Trial aims to examine the safety, feasibility and potential efficacy of intramuscularly injected allogeneic mesenchymal stromal cells as treatment for digital ulcers of systemic sclerosis.

This description comes directly from the study's public registry record.

Talk to the study team

Femke van Rhijn, MD  ·  0031887557329  ·  f.c.c.brouwer-3@umcutrecht.nl

Always discuss trial participation with your own doctor first.

Locations (1)

Universitair Medisch Centrum UtrechtUtrecht, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03211793